Separation of the Epitopes in a Multi-Epitope Chimera: Helical or Flexible Linkers.

Multi-epitope chimera expression level helical and flexible linkers immobilized metal ion affinity chromatography molecular modeling purified chimera

Journal

Protein and peptide letters
ISSN: 1875-5305
Titre abrégé: Protein Pept Lett
Pays: Netherlands
ID NLM: 9441434

Informations de publication

Date de publication:
2020
Historique:
received: 03 07 2019
revised: 25 09 2019
accepted: 29 09 2019
pubmed: 14 11 2019
medline: 16 1 2021
entrez: 14 11 2019
Statut: ppublish

Résumé

The engineered chimeric peptides including functional multi-epitope structures fused by various peptide linkers are widely applied in biotechnological research to improve the expression level and biological activity of chimera. The aim of our study was to evaluate the effect of helical and flexible linkers on solubility, expression level and folding of multi-epitope chimera containing four epitopes of Human T Lymphotropic Virus Type 1 (HTLV-1). For this purpose, the chimera sequences connected by the helical or flexible linker were inserted into different plasmid vectors and expressed in E. coli strains. The expressed products were analyzed using SDS-PAGE and Western blot techniques. Additionally, the molecular modeling study of the chimera with helical or flexible linker was performed using iterative threading assembly refinement (I-TASSER) to attain their three-dimensional structures. Comparison of the chimera expression indicated that the insertion of a flexible (GGGGS)3 linker among chimera epitopes could significantly enhance the level of expression, whereas, the low-level of chimera expression was observed for chimera containing the contiguous helical (EAAAK)5 linker. According to the results of sequence alignment and plasmid stability test, the structure and function of a consecutive helical linker among chimera epitopes were similar to porins as the outer-membrane pore-forming proteins. The molecular modeling results confirmed our experimental study. This investigation illustrated the key role of linker design in determining the expression level of multi-epitope chimera and conformational folding.

Sections du résumé

BACKGROUND BACKGROUND
The engineered chimeric peptides including functional multi-epitope structures fused by various peptide linkers are widely applied in biotechnological research to improve the expression level and biological activity of chimera.
OBJECTIVE OBJECTIVE
The aim of our study was to evaluate the effect of helical and flexible linkers on solubility, expression level and folding of multi-epitope chimera containing four epitopes of Human T Lymphotropic Virus Type 1 (HTLV-1).
METHODS METHODS
For this purpose, the chimera sequences connected by the helical or flexible linker were inserted into different plasmid vectors and expressed in E. coli strains. The expressed products were analyzed using SDS-PAGE and Western blot techniques. Additionally, the molecular modeling study of the chimera with helical or flexible linker was performed using iterative threading assembly refinement (I-TASSER) to attain their three-dimensional structures.
RESULTS RESULTS
Comparison of the chimera expression indicated that the insertion of a flexible (GGGGS)3 linker among chimera epitopes could significantly enhance the level of expression, whereas, the low-level of chimera expression was observed for chimera containing the contiguous helical (EAAAK)5 linker. According to the results of sequence alignment and plasmid stability test, the structure and function of a consecutive helical linker among chimera epitopes were similar to porins as the outer-membrane pore-forming proteins. The molecular modeling results confirmed our experimental study.
CONCLUSION CONCLUSIONS
This investigation illustrated the key role of linker design in determining the expression level of multi-epitope chimera and conformational folding.

Identifiants

pubmed: 31721685
pii: PPL-EPUB-102273
doi: 10.2174/0929866526666191112124602
doi:

Substances chimiques

Epitopes 0
Recombinant Fusion Proteins 0
Viral Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

604-613

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Mona Kabiri (M)

School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.

Mohsen Tafaghodi (M)

School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.

Mohammad Reza Saberi (MR)

Medical Chemistry Department, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.

Maliheh Moghadam (M)

Immunobiochemistry Lab, Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

Seyed Abdolrahim Rezaee (SA)

Department of Immunology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Mojtaba Sankian (M)

Department of Immunology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH